Studies on cell-mediated immunity in women using different fertility regulating methods

Area of Science:

• Immunology
• Reproductive Health
• Pharmacology

Background:

• Cell-mediated immunity (CMI) plays a crucial role in immune response.
• Fertility regulating methods, including hormonal contraceptives and intrauterine devices (IUDs), are widely used.
• Understanding the impact of these methods on CMI is essential for women's health.

Purpose of the Study:

• To assess the effect of different fertility regulating methods on cell-mediated immunity (CMI).
• To compare CMI levels in women using various contraceptives with those of controls.
• To investigate the duration-dependent effects of hormonal contraceptives on CMI.

Main Methods:

• Cell-mediated immunity (CMI) was evaluated using phytohaemagglutinin (PHA)-induced lymphocyte transformation.
• Women using intrauterine devices (IUCDs), estrogen-progestogen combination pills, or progestogen-only pills for varying durations (1-18 months) were studied.
• CMI was compared between treated groups, women on conventional contraception, and non-contraceptive users.

Main Results:

• No significant alteration in CMI was observed in women using IUCDs or estrogen-progestogen combination therapy.
• A significant suppression of CMI was noted in women using progestogen-only pills for 12-18 months.
• Short-term use (1-11 months) of combination therapy did not affect CMI, and in vitro studies showed suppressed lymphocyte transformation with estradiol and progesterone.

Conclusions:

• Long-term use of progestogen-only pills may suppress cell-mediated immunity.
• Combined hormonal contraceptives and IUCDs appear to have a neutral effect on CMI.
• Further research may be warranted to elucidate the precise mechanisms and clinical implications of these findings.